Literature DB >> 17708630

Ginkgo biloba extract prevents ethanol induced dyslipidemia.

Ping Yao1, Fangfang Song, Ke Li, Shaoliang Zhou, Shuang Liu, Xiufa Sun, Andreas K Nussler, Liegang Liu.   

Abstract

Ginkgo biloba extract (EGB) functions as a natural substantial antioxidant and hypolipidemic. Chronic alcohol abuse leads to sustained dyslipidemia characterized by hyperlipidemia and lipid peroxidation. Thus, the present study investigates the effect of EGB on lipid disorders induced by ethanol in rats. Male Sprague-Dawley rats were fed with ethanol (2.4 g/kg), and pretreated with a daily dose of low or high EGB (48 or 96 mg/kg, respectively). During the experiment, serum was collected on day 30, 60, and 90. Serum lipid profile, including lipid peroxidation, was determined by colorimetric methods. Our data showed that ethanol intake resulted in a time-dependent increase in serum levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and malondialdehyde (MDA), and a decrease of the ratio of high-density lipoprotein cholesterol (HDL-C) against TC. EGB prophylactic medication (48 and 96 mg/kg), especially at the high dose, significantly increased HDL-C content, and normalized the abnormal lipid profile and peroxidation in comparison to ethanol-fed only rats. These results suggest that ethanol results in time-dependent hypercholesterolemia, hypertriglyceridemia and promotes serum lipid peroxidation. EGB pretreatment prevents hyperlipidemia and ameliorates lipid peroxidation induced by ethanol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17708630     DOI: 10.1142/S0192415X07005132

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  13 in total

Review 1.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

2.  A rapid strategy for screening high-efficiency PCSK9 inhibitors from Ginkgo biloba leaves by ligand fishing, HPLC-Q-TOF-MS and interdisciplinary assay.

Authors:  Li Li; Meng-Lin Fan; Ya-Nan Li; Ya-Xuan Huang; Xiu-Feng Liu; Ji-Hua Liu
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

3.  Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats.

Authors:  Qi Zhang; Guang-ji Wang; Ji-ye A; Di Wu; Ling-ling Zhu; Bo Ma; Yu Du
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

4.  Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA.

Authors:  Chong-Zhi Wang; Ming Ni; Shi Sun; Xiao-Li Li; Hui He; Sangeeta R Mehendale; Chun-Su Yuan
Journal:  J Agric Food Chem       Date:  2009-03-25       Impact factor: 5.279

5.  In Vitro Screening for Cytotoxic Activity of Herbal Extracts.

Authors:  Valter R M Lombardi; Iván Carrera; Ramón Cacabelos
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-13       Impact factor: 2.629

6.  Ginkgo biloba Leaf Extract Protects against Myocardial Injury via Attenuation of Endoplasmic Reticulum Stress in Streptozotocin-Induced Diabetic ApoE-/- Mice.

Authors:  Jinfan Tian; Yanfei Liu; Yue Liu; Keji Chen; Shuzheng Lyu
Journal:  Oxid Med Cell Longev       Date:  2018-02-25       Impact factor: 6.543

Review 7.  Does Adjuvant Treatment With Ginkgo Biloba to Statins Have Additional Benefits in Patients With Dyslipidemia?

Authors:  Yu Fan; Xin Jin; Changfeng Man; Dandan Gong
Journal:  Front Pharmacol       Date:  2018-06-22       Impact factor: 5.810

8.  Ginkgo biloba induces different gene expression signatures and oncogenic pathways in malignant and non-malignant cells of the liver.

Authors:  Carolin Czauderna; Mayrel Palestino-Dominguez; Darko Castven; Diana Becker; Luis Zanon-Rodriguez; Jovana Hajduk; Friederike L Mahn; Monika Herr; Dennis Strand; Susanne Strand; Stefanie Heilmann-Heimbach; Luis E Gomez-Quiroz; Marcus A Wörns; Peter R Galle; Jens U Marquardt
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

9.  Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats.

Authors:  Daye Cheng; Bin Liang; Yunhui Li
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

10.  Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.

Authors:  Ki-Jong Rhee; Chang Gun Lee; Sung Woo Kim; Dong-Hyeon Gim; Hyun-Cheol Kim; Bae Dong Jung
Journal:  Int J Med Sci       Date:  2015-11-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.